Compass Pathways is a pharmaceutical preparations company trading on NASDAQ, led by CEO Kabir Kumar Nath.
Upcoming earnings announcement for Compass Pathways
Past 12 earnings reports for Compass Pathways
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 24, 2026 | Q4 2025 | -$0.59Est: -$0.40 | -47.5% | - | — | |
| Nov 4, 2025 | Q3 2025 | -$0.38Est: -$0.40 | +5.0% | - | — | |
| Jul 31, 2025 | Q2 2025 | -$0.41Est: -$0.38 | -7.9% | - | — | |
| May 8, 2025 | Q1 2025 | -$0.24Est: -$0.49 | +51.0% | - | — | |
| Feb 27, 2025 | Q4 2024 | -$0.63Est: -$0.62 | -1.6% | - | — | |
| Oct 31, 2024 | Q3 2024 | -$0.56Est: -$0.57 | +1.8% | - | — | |
| Aug 1, 2024 | Q2 2024 | -$0.56Est: -$0.53 | -5.7% | - | — | |
| May 8, 2024 | Q1 2024 | -$0.55Est: -$0.49 | -12.2% | - | — | |
| Feb 29, 2024 | Q4 2023 | -$0.53Est: -$0.33 | -60.6% | - | — | |
| Nov 2, 2023 | Q3 2023 | -$0.67Est: -$0.43 | -55.8% | - | — | — |
| Aug 3, 2023 | Q2 2023 | -$0.62Est: -$0.69 | +10.1% | - | — | |
| May 11, 2023 | Q1 2023 | -$0.57Est: -$0.68 | +16.2% | - | — | — |
We use cookies for analytics. See our Privacy and Cookie Policy.